* Moody’s on Teva Pharmaceutical – there is no change to
Teva Pharmaceutical Industries LTD Baa2 senior unsecured rating
or stable outlook
Source text for Eikon:
The post BRIEF-Moody’s says Teva’s loss of two copaxone patents is credit negative appeared first on NASDAQ.